+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Global Lupus Therapeutic Market 2017-2021 - Product Thumbnail Image

Global Lupus Therapeutic Market 2017-2021

  • Report
  • June 2017
  • 82 Pages
From
Global Celiac Disease Drugs Market 2017-2021 - Product Thumbnail Image

Global Celiac Disease Drugs Market 2017-2021

  • Report
  • June 2017
  • 76 Pages
From
From
From
From
From
From
Primary Immune Deficiency (PID) - Pipeline Review, H1 2020 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 125 Pages
From
Primary Immune Deficiency (PID) - Pipeline Insight, 2020 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
Global Lymphoma Drugs Market 2017-2021 - Product Thumbnail Image

Global Lymphoma Drugs Market 2017-2021

  • Report
  • June 2017
  • 86 Pages
From
From
Loading Indicator
adroll